Skip to main content

Proteasome Inhibitors

Proteasome inhibitors are used to treat non-Hodgkin's lymphoma and multiple myeloma. They work by preventing the growth of cancer cells in the body.

Why are proteasome inhibitors prescribed?

  1. Non-Hodgkin Lymphoma (50%)
  2. Multiple Myeloma (50%)

Key takeaways

Proteasome inhibitors are used to treat conditions such as multiple myeloma and mantle cell lymphoma. These medications work by blocking proteasomes inside of cancer cells, which helps to kill the cancer cells. Proteasome inhibitors come in different forms, including oral pills and injections. Examples include Velcade (bortezomib), Kyprolis (carfilzomib), and Ninlaro (ixazomib).

Prices for popular Proteasome Inhibitors medications
Viewing 3 of 3 medications
BORTEZOMIB treats lymphoma. It may also be used to treat multiple myeloma, a type of bone marrow cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
CARFILZOMIB treats multiple myeloma, a type of bone marrow cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
IXAZOMIB treats multiple myeloma, a type of bone marrow cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By signing up, I agree to GoodRx’s Terms of Use and Privacy Policy, and to receive marketing messages from GoodRx.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.